Compensation

How participants are compensated

NRI provides financial compensation to all study participants to recognize the time, travel, and effort required to complete a clinical trial. Compensation amounts vary by study depending on the number of visits, the length of participation, and the demands of the protocol.

Compensation is paid incrementally as you complete scheduled visits, not as a lump sum at the end. This means if you need to withdraw before the study concludes, you are compensated for the participation you completed. Compensation is provided regardless of which study group you are assigned to, active product or placebo.

Compensation amounts for each study are listed on the individual study page. They are designed to be fair recognition of your time without creating pressure to participate in research you would otherwise decline. If you have questions about compensation before applying, contact us.

NRI studies have one of the highest participant retention rates in the field. 95% or more of enrolled participants complete their studies. That is a reflection of how we treat people, not just how we design protocols.

General eligibility

Who can typically participate in NRI studies

Each study has its own specific eligibility criteria listed in the study description. The criteria below represent general patterns across NRI trials. Meeting these general criteria does not guarantee eligibility for any specific study.

Generally eligible

Generally healthy adults or children within the study's specified age range
Experiencing the condition or symptom the study is targeting, at a level that meets study thresholds
Able to attend scheduled visits at the NRI facility in Huntsville, Alabama
Able to read, understand, and sign the informed consent document
Willing to follow the study protocol for the full duration
Not currently enrolled in another clinical trial

Common exclusions

Active serious medical conditions including cardiovascular disease, autoimmune conditions, and active cancer
Current use of medications that may interact with the study product, specified per study
Pregnancy or breastfeeding, except in studies specifically designed for those populations
Known allergy to any study product ingredient
Recent use of products similar to the study intervention, within a washout period specified per study

These are general patterns only. Apply even if you are unsure. We screen every applicant individually and will tell you honestly whether you qualify. Many people who assume they do not qualify actually do.

What participation involves

A realistic picture of what we ask

Time commitment

Study duration ranges from 4 weeks to 16 weeks depending on the protocol. Most studies require between 2 and 6 in-person visits at the NRI facility in Huntsville. Each visit typically lasts 30 to 90 minutes. Between visits, home-based activities are usually brief, 5 to 15 minutes per day for questionnaire completion or product use.

Product use

Most NRI studies involve taking a supplement or using a product daily for the study duration. The specific product, format, dose, and schedule are described in the informed consent document before you commit. Some studies use placebo. You may or may not know which group you are in, depending on the study design.

Questionnaires and assessments

NRI uses validated psychometric instruments to measure outcomes. You will complete questionnaires about your symptoms, wellbeing, and experience at scheduled intervals. These are not onerous. Most take 5 to 15 minutes. They are the primary way we measure whether the product is working.

Optional blood draws

Some studies include optional or required blood draws to measure biomarkers alongside the questionnaire data. Whether blood draws are involved, how many, and what they measure is specified in the study listing and informed consent. You are never required to provide samples beyond what the protocol specifies.

Ready to apply?

View currently enrolling studies and apply online. We respond within five business days.

See open studies